SCHEMBL7745480

SCHEMBL7745480

Cc1nn(Cc2nc3ccccc3n2CCN(C)C)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.47
GLS O94925 1/20 0.47
POLB P06746 1/20 0.46
GAA P10253 1/20 0.43
PKM P14618 1/20 0.42
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
EP300 Q09472 1/20 0.41
CREBBP Q92793 1/20 0.41
TERT O14746 1/20 0.41
RECQL P46063 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7740578 0.87 TOP2A (0.46) TOP2APOLBGAAKDM4EMEN1
SCHEMBL7745467 0.87 TOP2A (0.49) TOP2APOLBGAAKDM4EMEN1
SCHEMBL7746704 0.83 TOP2A (0.55) TOP2APOLBGAAPKMKDM4E
SCHEMBL5858823 0.80 POLB (0.48) TOP2APOLBGAAKMT2AALDH1A1
SCHEMBL7747969 0.80 TOP2A (0.46) TOP2APOLBPKMKDM4EMEN1
Hydrochloric Acid SCHEMBL5859906 0.79 POLB (0.47) POLBGAAPKMKMT2AALDH1A1
SCHEMBL7744925 0.79 POLB (0.47) TOP2APOLBPKMKDM4EMEN1
SCHEMBL5858794 0.77 POLB (0.43) TOP2APOLBGAAPKMKDM4E
SCHEMBL7745595 0.75 LMNA (0.65) POLBPKMMEN1KMT2AALDH1A1
SCHEMBL7740999 0.75 HTR2A (0.61) TOP2APOLBPKMKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed